GPR-55 neoantigen (Complete Genomics/Sichuan University/Stanford University/NIH)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGPR-55 neoantigen (Complete Genomics/Sichuan University/Stanford University/NIH)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesComplete Genomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesComplete Genomics IncNational Institutes Of HealthStanford University +[4] 
Active IndicationsN/A
Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A